Martínez-Rivera FJ

📢📍The Martínez-Rivera Lab focused on (Mal)adaptive & Neurobehavioral Plasticity is opening this summer/fall at @UFNeuroscience @UFMBI. We'll be hiring at all levels, please share! Academia might not be perfect, but it gave me purpose in life. 🙌🏽 💫💎☀️🎉🐊

Proud to announcement publication of a study by @FreddysonJ, @holtlm90, and others in Nat. Commun. that report the transcriptional underpinnings in nucleus accumbens of withdrawal vs. extinction from cocaine self-administration. @SinaiBrain nature.com/articles/s4146…

This speaks to the importance of cross-species research that is constantly forward & back-translated between the clinic & lab. The importance of animal models leading to unanticipated discoveries - even in the realm of human psychology - is invaluable, especially in #psychiatry🧠

The lab of Dr. Freddyson Martinez-Rivera investigates behaviors related to substance abuse disorders, impaired decision-making and mood disorders. #MBI_Labs Learn more: bit.ly/3ZvPOUz

📢 Don't miss our recent review on the "Neurobiology of resilience to early life stress", published in @npp_journal! Great collaboration along with Alessandro Bortolami, Cathe Peña, and @EricJNestler. 👇👇 nature.com/articles/s4138…

Excited to share the preprint for one of my postdoctoral projects in the Nestler lab 🥳 biorxiv.org/content/10.110…

🚨 New in @NatureComms: We present a spatial multi-omics platform that maps the metabolome, lipidome, and glycome from a single brain section. Combining MALDI imaging with our computational tool Sami, we reveal metabolic diversity in health and Alzheimer's disease. 🔗…

Please see this new publication by Arthur Godino, Marine Salery, and others now online in @Nature. We show opposite roles for D1 vs D2 dopamine receptor- expressing neurons in ventral hippocampus in controlling approach-avoidance behavior. @SinaiBrain rdcu.be/ek2DS

Both my current PI, @EricJNestler, and my PhD advisor, @hamm_heidi, have just been elected to the NAS! I’m incredibly honored to have been mentored by such brilliant scientists. Huge congratulations to both🎉🎉

YOUR 2025 NATIONAL CHAMPIONS.

Of >105,000 participants with 30-year follow-up, only 9.3% achieved healthy aging (age 70, w/o any chronic diseases). Their diet was significantly associated with this outcome🧵 @NatureMedicine

Treatment-resistant depression (TRD) is a condition affecting ~30% of patients treated with conventional antidepressants. Here, we profiled transcriptional changes potentially underlying TRD in a stress model. @GylesTrevonn @ericMparise @EricJNestler 👇👇 biorxiv.org/content/10.110…

See the amazing line up of speakers for the Catecholamines GRC! Apply for GRC grc.org/catecholamines… & GRS grc.org/catecholamines…. In these uncertain times we appreciate any donation to support the participants in the GRC my.grc.org/p/contribution… & GRS my.grc.org/p/contribution…

Transcriptional Profiles in Nucleus Accumbens of Antidepressant Resistance in Chronically Stressed Mice biorxiv.org/content/10.110… #biorxiv_neursci

Thank you for the highlight! 🙏🏽💫💎🐊

Our latest MBI Researcher Highlight features Dr. Freddyson Martínez-Rivera, a @UF assistant professor of neuroscience who studies adaptive & dysfunctional behaviors in substance abuse, impaired decision-making and mood-associated disorders. Learn more: bit.ly/4i6N739

We are pleased to announce the opening of applications for the 2025 BBRF Young Investigator Grant. All applications must be submitted online. Please visit our website to submit your application. ow.ly/BWxK50URsiH . #mentalhealth #neuroscience #mentalillness